Surrogate endpoints: a key concept in clinical epidemiology

Area of Science:

• Clinical Trial Design
• Biomarker Validation
• Health Outcomes Research

Background:

• Surrogate endpoints are intermediate measures used in clinical research as substitutes for direct patient-important outcomes.
• Patient-centered outcomes are health results of direct relevance and importance to patients.
• The use of surrogate endpoints can expedite research and decision-making processes.

Purpose of the Study:

• To elaborate on the understanding and application of surrogate endpoints in clinical research.
• To define the scientific criteria necessary for a valid surrogate endpoint.

Main Methods:

• Review and synthesis of scientific literature on surrogate endpoint validation.
• Elaboration on the biological plausibility and threshold effect requirements for surrogate endpoints.
• Emphasis on the need for robust scientific evidence and rigorous evaluation.

Main Results:

• A scientifically grounded relationship between surrogate and patient-important endpoints is crucial.
• Biologically plausible and predictable reflection of patient outcomes by the surrogate is necessary.
• A threshold effect demonstrating a link between surrogate change and patient outcome is required.

Conclusions:

• Surrogate endpoints offer advantages but require careful validation to ensure they reliably predict clinical outcomes.
• The validity of surrogate endpoints depends on robust scientific evidence and rigorous evaluation.
• Misuse or mislabeling of surrogate endpoints can lead to flawed research and decision-making.